SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassian is trending after reporting a strong fiscal third-quarter beat, with revenue and cloud growth figures providing a significant relief rally for the beaten-down software sector. The community is actively debating whether this performance marks the end of the 'SaaS-pocalypse' or if it is merely a temporary bounce, while many investors highlight Atlassian's AI-driven Rovo integration as a critical long-term catalyst for share price recovery.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR is currently capturing community attention due to the rollout of new AI-integrated staking features and its expanding role in AI infrastructure, which has triggered debates between those seeing long-term value and those concerned about short-term bearish technical setups. While retail traders remain divided over its volatility and price action, ongoing discussions are heavily focused on NEAR's potential utility as an AI-native layer within the broader crypto ecosystem.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is seeing increased social sentiment and trading volume as investors debate its potential for a recovery, bolstered by its focus on quantum-resistant cryptography and enterprise-grade performance. While some community members remain skeptical of long-term price action, many are actively accumulating during recent dips, citing optimism around institutional integration and future regulatory developments.

Hycroft Mining Holding Corp. engages in the exploration, mining, and development of gold and silver properties. The company was founded on August 28, 2017 and is headquartered in Winnemucca, NV.

Hycroft Mining Holding Corporation - Ordinary Shares - Class A

Hycroft Mining Holding Corp

Hycroft Mining Holding Corp is generating significant community debate, polarized between investors betting on its massive untapped resource potential and vocal critics pointing to severe cash burn and pre-production operational risks. The stock remains a high-volatility focus as speculators monitor global precious metals demand, insider accumulation by Eric Sprott, and the company's complex transition toward an executable mine plan.

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Abbvie Inc

AbbVie is trending as investors digest the recent $10.9 billion acquisition of Apogee Therapeutics, a deal aimed at strengthening its immunology pipeline and securing long-term growth. While the community is actively debating the high premium paid and the long-term impact on earnings, the stock remains a key focus due to its strong dividend profile and ongoing competition in the immunology sector.

Barrick Mining Corp. engages in the production and sale of gold, copper, and related activities. It also provides exploration and mining development. It operates through the following business segments: Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, Bulyanhulu, and Other Mines. The company was founded by Peter D. Munk in 1983 and is headquartered in Toronto, Canada.

Barrick Mining Corp.

Barrick Mining Corp

Barrick Mining is capturing significant market attention as investors weigh the company's dual-commodity focus on gold and copper against the risks of geopolitical instability and rising mining costs. The community is actively debating the upcoming North American IPO and the impact of the company's aggressive share buyback program amidst broader concerns about global economic debt, inflation, and the shifting role of gold in central bank reserve strategies.

Securitize Corp. is a financial technology company, which engages in the provision of regulated infrastructure for the issuance, management, trading, and administration of tokenized real-world assets (RWAs). The company was founded on October 17, 2025 and is headquartered in Miami, FL.

Securitize Corp.

Securitize Corp. is trending as investors debate its role as a pure-play leader in the tokenized real-world asset (RWA) space, with community sentiment split between excitement over institutional partnerships like BlackRock and frustration over post-SPAC price volatility. While retail participants are actively monitoring catalysts such as the potential passing of the Clarity Act and ongoing share accumulation by firms like ARK Invest, the conversation remains focused on the company's long-term infrastructure potential versus immediate technical selling pressure.

Strive, Inc. engages in the provision of an asset management Bitcoin treasury. It is focused on maximizing value for shareholders, accumulating bitcoin and outperforming bitcoin over the long run. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani, and Kyle Fairbanks on March 9, 2022 and is headquartered in Dallas, TX.

Strive Inc. - Ordinary Shares - Class A

Strive Inc.

Strive Inc. is currently a focal point for investors debating the efficacy of Bitcoin treasury strategies, with community members actively weighing the company's daily dividend model against concerns regarding share dilution and capital allocation. The stock remains a high-conviction topic for many as traders monitor its price action relative to Bitcoin's volatility and evaluate the sustainability of its financial structure compared to sector peers.

ProShares Trust - ProShares UltraPro Short QQQ -3x Shares

ProShares UltraPro Short QQQ

The SQQQ is trending as investors aggressively hedge against potential volatility and leverage-driven market corrections, fueled by anxiety over AI sector valuations and mounting geopolitical tensions in the Middle East. Community discussion is dominated by a sharp divide between retail traders betting on an imminent crash and those criticizing the underlying mechanics of leveraged inverse ETFs as a risky strategy.

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Immix Biopharma Inc

Immix Biopharma is trending as community discussions focus on its NEXICART-2 trial progress, following the appointment of a new CMO with significant BLA experience and recent institutional interest from major firms like Janus Henderson. Investors are actively debating the potential for an accelerated FDA path and the strength of the company's clinical data in AL amyloidosis, while monitoring for a high-impact topline data readout later this year.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
